Author

Barry Martin

University of Colorado Anschutz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amanda A. HilliD· 1 shared Angela L. RachubinskiiD· 1 shared Belinda A Enriquez Estrada· 1 shared Cory A. DunnickiD· 1 shared David Albert NorrisiD· 1 shared Deborah J. FidleriD· 1 shared Eleanor C. Britton· 1 shared Elizabeth B. WallaceiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Amanda A. HillORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

JAK inhibition decreases the autoimmune burden in Down syndrome

Angela L. Rachubinski, Elizabeth B. Wallace, Emily Gurnee, Belinda A Enriquez Estrada, Kayleigh R Worek, Keith P. Smith, Paula Araya, Katherine A. Waugh, Ross E. Granrath, Eleanor C. Britton, Hannah R. Lyford, Micah G. Donovan, Neetha Paul Eduthan, Amanda A. Hill, Barry Martin, , Joaquin Maximiliano Espinosa

This study investigates immune dysregulation in Down syndrome and shows that JAK inhibition with tofacitinib reduces autoimmune symptoms and inflammatory markers without significant adverse effects.

eLife · Dec 31, 2024Peer-reviewedGenetic & Genomic Medicine